| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | — |
| R&D Expense | $97.2M | +28.5% |
| SG&A Expense | $31.9M | +65.6% |
| Operating Income | -$133.8M | -41.0% |
| Interest Expense | $1.4M | +10.1% |
| Pre-tax Income | -$130.8M | -36.6% |
| Income Tax | $91K | +111.6% |
| Net Income | -$130.9M | -36.6% |
| EPS (Basic) | -$2.27 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.3M | +49.3% |
| Short-term Investments | $231.2M | +38.9% |
| Current Assets | $319.7M | +40.1% |
| Total Assets | $486.5M | +11.2% |
| Current Liabilities | $29.8M | +90.5% |
| Long-term Debt | $10.4M | +0.0% |
| Total Liabilities | $183.8M | +346.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.1M | +115.8% |
| Capital Expenditures | $30.6M | -31.9% |
| Investing Cash Flow | -$13.1M | +95.6% |
| Financing Cash Flow | $27.2M | -93.5% |
| Free Cash Flow | -$16.6M | +87.6% |
| +23.3% |
| EPS (Diluted) | -$2.27 | +23.3% |
| Stockholders' Equity |
| $302.7M |
| -23.6% |